Science Explorer Back to mapMap

Most cited papers from Sigma-Tau (Switzerland)

What are the most cited papers from Sigma-Tau (Switzerland)?

The most cited paper from Sigma-Tau (Switzerland) is "Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production" (Silvana Obici, Zhaohui Feng, Arduino Arduini et al., 2003), with 562 citations. Next come "Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension" (530) and "Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma" (483).

Showing 50 of 62 papers. Every paper with more than 69 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production Silvana Obici, Zhaohui Feng, Arduino Arduini et al. · Nature Medicine 18 May 2003 562
2 Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension Daniele Cusi, Cristina Barlassina, Tiziana Azzani et al. · The Lancet May 1997 530
3 Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma Christopher James Gibson et al. · Journal of Clinical Oncology Open access 23 Feb 2017 483
4 Polyunsaturated Fatty Acids: Biochemical, Nutritional and Epigenetic Properties Paola Benatti, Gianfranco Peluso, Raffaella Nicolai et al. · Journal of the American College of Nutrition Aug 2004 451
5 Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial Sergio Amadori et al. · Journal of Clinical Oncology Open access 25 Jan 2016 361
6 Biochemical and functional characterization of the interaction between pentraxin 3 and C1q Alma J. Nauta, Barbara Bottazzi, Alberto Mantovani et al. · European Journal of Immunology 27 Jan 2003 354
7 Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease Kathy E. Sietsema, Antonino Amato, Sharon G. Adler et al. · Kidney International Open access 8 Jan 2004 338
8 Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation Cristina Cunha et al. · New England Journal of Medicine Open access 29 Jan 2014 314
9 Pharmacokinetics of L-Carnitine Allan M. Evans, Gianfranco Fornasini · Clinical Pharmacokinetics 2003 304
10 Two point mutations within the adducin genes are involved in blood pressure variation. Giuseppe Bianchi, Grazia Tripodi, Giorgio Casari et al. · Proceedings of the National Academy of Sciences Open access 26 Apr 1994 279
11 Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. Grazia Tripodi, Flavia Valtorta, Lucia Torielli et al. · Journal of Clinical Investigation Open access 15 Jun 1996 252
12 SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis Joseph P. Ritchie, Vishnu C. Ramani, Yongsheng Ren et al. · Clinical Cancer Research Open access 21 Jan 2011 250
13 Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Vincenzo Mazzaferro, Jorgelina Clara Coppa, Matteo Giovanni Carrabba et al. · PubMed 15 Aug 2003 240
14 Vaccines against Toxoplasma gondii: challenges and opportunities Erik Jongert, Craig W. Roberts, Nicola Gargano et al. · Memórias do Instituto Oswaldo Cruz Open access Mar 2009 206
15 Role of the soluble pattern recognition receptor PTX3 in vascular biology Marco Presta, Maura Camozzi, Giovanni Salvatori et al. · Journal of Cellular and Molecular Medicine Open access 24 Jun 2007 180
16 Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin, Part 2: Clinical Studies Chiara Livia Lanzani, Lorena Citterio, Nicola Glorioso et al. · Science Translational Medicine Open access 24 Nov 2010 173
17 Left Ventricular Mass, Stroke Volume, and Ouabain-Like Factor in Essential Hypertension Paolo Manunta, Paola Stella, Rodolfo Fernando Rivera et al. · Hypertension Sep 1999 168
18 Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent Mihai Gheorghiade, John E. Blair, Gerasimos S Filippatos et al. · Journal of the American College of Cardiology Open access 10 Apr 2008 165
19 Association of the α-Adducin Locus With Essential Hypertension Giorgio Casari, Cristina Barlassina, Daniele Cusi et al. · Hypertension Mar 1995 158
20 Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions Menotti Calvani, Emilia Reda, Edoardo Arrigoni‐Martelli · Basic Research in Cardiology Apr 2000 155
21 A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease Leon J. Thal, Angelico Carta, William R. Clarke et al. · Neurology Sep 1996 151
22 Organ Hypertrophic Signaling within Caveolae Membrane Subdomains Triggered by Ouabain and Antagonized by PST 2238 Mara Ferrandi, Isabella Molinari, Paolo Barassi et al. · Journal of Biological Chemistry Open access Jun 2004 150
23 The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D 2 /A 2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease Alessandro Tozzi, Antonio de Iure, Massimiliano Di Filippo et al. · Journal of Neuroscience Open access 2 Feb 2011 149
24 Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008 Chezi Ganzel, Judith B. Manola, Dan Douer et al. · Journal of Clinical Oncology Open access 29 Aug 2016 137
25 Food, Nutrigenomics, and Neurodegeneration—Neuroprotection by What You Eat! Ashraf Virmani, Luigi Pinto, ZBIGNIEW K. BINIENDA et al. · Molecular Neurobiology 27 Jun 2013 136
26 Anti- Aspergillus fumigatus Efficacy of Pentraxin 3 Alone and in Combination with Antifungals Roberta Gaziano, Silvia Bozza, Silvia Bellocchio et al. · Antimicrobial Agents and Chemotherapy Open access 25 Oct 2004 134
27 Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation Silvia Bozza, Francesco Bistoni, Roberta Gaziano et al. · Blood Open access 14 Jul 2006 131
28 Evidence for an interaction between adducin and Na+-K+-ATPase: relation to genetic hypertension Mara Ferrandi, Sergio Salardi, Grazia Tripodi et al. · American Journal of Physiology-Heart and Circulatory Physiology Oct 1999 130
29 Enhanced Piola–Hencky discrete models for pantographic sheets with pivots without deformation energy: Numerics and experiments Emilio Turco, Anil Kumar Misra, Marek Pawlikowski et al. · International Journal of Solids and Structures Open access 17 May 2018 128
30 Involvement of FIS in the H‐NS‐mediated regulation of virF gene of Shigella and enteroinvasive Escherichia coli ‡ Maurizio Falconi, Gianni Prosseda, Mara Giangrossi et al. · Molecular Microbiology Open access Oct 2001 125
31 Microwires coated by glass: A new family of soft and hard magnetic materials Arcady Zhukov, J. González, J.M. Blanco et al. · Journal of materials research/Pratt's guide to venture capital sources Oct 2000 122
32 Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells Licia Rivoltini, Chiara Castelli, Matteo Giovanni Carrabba et al. · The Journal of Immunology Open access Oct 2003 121
33 Novel Camptothecin Analogue (Gimatecan)‐Containing Liposomes Prepared by the Ethanol Injection Method Pasquale Stano, Simone Bufali, Claudio Pisano et al. · Journal of Liposome Research 2004 113
34 Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension Paolo Ferrari, Mara Ferrandi, Giovanni Valentini et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 8 Feb 2006 111
35 Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth Factor Marcella Marcellini, Naomi De Luca, Teresa Riccioni et al. · American Journal Of Pathology Open access Aug 2006 107
36 Plasma carnitine insufficiency and effectiveness of L ‐carnitine therapy in patients with mitochondril myopathy Yolanda Campos, Rosa Huertas, Gustavo Lorenzo et al. · Muscle & Nerve Feb 1993 103
37 Protective actions of l-carnitine and acetyl-l-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors Ashraf Virmani, Roberto Biselli, A. Spadoni et al. · Pharmacological Research Dec 1995 103
38 Double‐blind, randomised, placebo‐controlled trial on the effect of L‐carnitine and L‐acetylcarnitine on sperm parameters in men with idiopathic oligoasthenozoospermia S. Mičić, Nataša Lalić, Dejan Djordjević et al. · Andrologia Open access 15 Mar 2019 101
39 Asymmetric biocatalysis with microbial enzymes and cells Roland Wohlgemuth · Current Opinion in Microbiology Review 30 Apr 2010 101
40 A double‐blind, parallel, multicenter comparison of L ‐acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys Maria Giulia Torrioli et al. · American Journal of Medical Genetics Part A 19 Feb 2008 101
41 PST2238: A New Antihypertensive Compound That Antagonizes the Long-Term Pressor Effect of Ouabain Paolo Ferrari, Lucia Torielli, Mara Ferrandi et al. · Journal of Pharmacology and Experimental Therapeutics Apr 1998 95
42 Aging brain: effect of acetyl-l-carnitine treatment on rat brain energy and phospholipid metabolism. A study by31P and1H NMR spectroscopy Tommaso Aureli, Alfredo Miccheli, Rita Ricciolini et al. · Brain Research Aug 1990 87
43 The enhancement of antiproliferative and proapoptotic activity of HDAC inhibitors by curcumin is mediated by Hsp90 inhibition Chiara Giommarelli, Valentina Zuco, Enrica Favini et al. · Cellular and Molecular Life Sciences Open access 28 Dec 2009 87
44 High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects PAOLO RIZZON, Giuseppina Biasco, Matteo Di Biase et al. · European Heart Journal Jun 1989 86
45 Assessing Progress, Impact, and Next Steps in Rolling Out Voluntary Medical Male Circumcision for HIV Prevention in 14 Priority Countries in Eastern and Southern Africa through 2014 Katharine E. Kripke, Emmanuel Njeuhmeli, Julia L. Samuelson et al. · PLoS ONE Open access 21 Jul 2016 85
46 Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma Vishnu C. Ramani, Fenghuang Zhan, Jianbo He et al. · Oncotarget Open access 27 Nov 2015 85
47 Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype Vishnu C. Ramani, Israël Vlodavsky, Mary Ng et al. · Matrix Biology Open access 22 Mar 2016 85
48 Hemodynamic Properties of a New-Generation Positive Luso-Inotropic Agent for the Acute Treatment of Advanced Heart Failure Hani N. Sabbah, Makoto Imai, Doug Cowart et al. · The American Journal of Cardiology 19 Sep 2006 81
49 The locks and keys to industrial biotechnology Roland Wohlgemuth · New Biotechnology 22 Jan 2009 81
50 Plasma and Muscle Carnitine Levels in Haemodialysis Patients with Morphological-Ultrastructural Examination of Muscle Samples Vincenzo Savica, Guido Bellinghieri, Carmelo Di Stefano et al. · ˜The œNephron journals/Nephron journals 3 Dec 2008 81

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.